Todd F Watanabe's Securities Transactions in Arcutis Biotherapeutics Inc

Todd F Watanabe, an officer of Arcutis Biotherapeutics Inc, has filed a Form 144 notice indicating the intent to sell 40,000 shares of common stock. The shares were acquired through restricted stock vesting on 03/01/2025 and 02/01/2025. The aggregate market value of the shares to be sold is approximately $1,001,032.56. Additionally, Watanabe has sold shares in the past three months, with transactions totaling $1,226,415 in gross proceeds. The sales occurred on various dates, including 10/02/2025, 10/01/2025, 09/09/2025, 09/08/2025, and 08/04/2025. The shares are traded on NASDAQ.